AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Hinge Health, Inc.
Video analysis: HNGE
All videosNo video analysis for this stock yet. Request one from our team.
News: HNGE
James Budge Sells 55,561 Shares of Hinge Health (NYSE:HNGE) Stock
Hinge Health Inc. (NYSE: HNGE - Get Free Report) CFO James Budge sold 55,561 shares of Hinge Health stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $89.45, for a total transaction of $4,969,931.45. Following the completion of the transaction, the chief financial officer owned 349,062 shares in
Concurrent Investment Advisors LLC Decreases Stock Position in Hinge Health Inc. $HNGE
Concurrent Investment Advisors LLC reduced its position in Hinge Health Inc. (NYSE: HNGE) by 45.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,219 shares of the company's stock after selling 10,083 shares during the quarter. Concurrent Investment Advisors LLC's holdings
Hinge Health Director Kristina Leslie Sells 1,200 Shares for $105,876
The transaction reduced her direct equity position by 4% while maintaining a multi-million dollar stake in the company. This disposition involved directly held shares only, with no indirect holdings reported in the filing.
Hinge Health Inc. (HNGE) Up 13.7% Since Last Earnings Report: Can It Continue?
Hinge Health Inc. (HNGE) reported earnings 30 days ago. What's next for the stock?
15 Stocks to Watch With Short Squeeze Potential
Bond yields have the entire stock market on edge. The last thing most investors are thinking about is short squeezes, which means maybe they should be something contrarian trades have on their radar.
IPO Stock Of The Week: Hinge Health Finds Support At Key Level, Eyes New Buy Points
Hinge stock found support at a key level in recent weeks and is approaching multiple new buy points despite market weakness.
One Platform, Every Ailment: Hinge Health's Gamble
Many people know that seemingly unrelated symptoms can be connected. But in most cases, treating individual symptoms means a separate doctor visit, sometimes to different specialists, before the full picture emerges.
HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?
Hinge Health's nearly 90% YTD surge is backed by 53% revenue growth, wider margins and expansion into migraine and GI care, but execution risks remain.
